US Health and Human Services Secretary Robert F. Kennedy Jr. pledged in April that there would be answers on the causes of autism this month. Since then, he has ousted public health officials, ...

The high-quality part of the content will begin with the preliminary preparations, introducing how to clarify the goals and ...

The US Food and Drug Administration on Wednesday approved Gilead Sciences' twice-yearly injection to prevent HIV -- a move the company hailed as a major breakthrough in the fight against the sexually ...

Investing.com -- Gilead Sciences (NASDAQ:GILD) said Tuesday it has received European Commission (EC) approval for its twice-yearly injection to prevent HIV, a key regulatory milestone following its ...

The US Food and Drug Administration on Wednesday approved Gilead Sciences' twice-yearly injection to prevent HIV -- a move the company hailed as a major breakthrough in the fight against the sexually ...

The two antiretroviral-containing injections leading the field are long-acting cabotegravir and lenacapavir. The health department has plans to roll out lenacapavir, a twice-yearly HIV prevention ...

New HIV prevention injection could be a ‘game changer,’ … News / 1 hour ago ...

According to Precedence Research, the global water for injection market size accounted for USD 37.99 billion in 2025 and is expected to grow from USD 42.13 billion in 2026 to approximately USD 87.39 ...

The health department has plans to roll out lenacapavir, a twice-yearly HIV prevention injection, in a select group of public sector clinics by April 2026. Meanwhile, little progress has been made ...